June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Visual Acuity Loss In Patients With AMD, Measured Using A Vanishing Optotype Letter Chart
Author Affiliations & Notes
  • Nilpa Shah
    NIHR Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital & UCL Institute of Ophthalmology, London, United Kingdom
  • Roger Anderson
    NIHR Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital & UCL Institute of Ophthalmology, London, United Kingdom
    Vision Science Research Group, School of Biomedical Sciences, University of Ulster at Coleraine, Northern Ireland, United Kingdom
  • Adnan Tufail
    NIHR Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital & UCL Institute of Ophthalmology, London, United Kingdom
  • Catherine Egan
    NIHR Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital & UCL Institute of Ophthalmology, London, United Kingdom
  • Steven Dakin
    NIHR Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital & UCL Institute of Ophthalmology, London, United Kingdom
  • Footnotes
    Commercial Relationships Nilpa Shah, None; Roger Anderson, None; Adnan Tufail, Allergan (C), Bayer (C), GSK (C), Oculogics (C), Pfizer (C), Thrombogenics (C), Amakem (C), Heidelberg Engineering (R), Novarits/Alcon (C), Sanofi/Genzyme (C); Catherine Egan, Bayer (S), Oculogics (S), Novartis (S), Allergan (S), Novartis (F); Steven Dakin, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 5021. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Nilpa Shah, Roger Anderson, Adnan Tufail, Catherine Egan, Steven Dakin; Visual Acuity Loss In Patients With AMD, Measured Using A Vanishing Optotype Letter Chart. Invest. Ophthalmol. Vis. Sci. 2013;54(15):5021.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Vanishing Optotype (VO) letters have a pseudo high-pass design so that the mean luminance of the target is the same as the background and the letters thus ‘vanish’ once the resolution threshold is reached in the fovea. We wished to investigate how visual acuity measurements using charts constructed from these letters compared to charts of conventional letter design, in both normal subjects and patients with differing levels of AMD.

Methods: 60 participants were recruited; 30 with no ocular abnormalities and 30 with AMD and no other significant ocular pathology. Following refractive error correction, each subject underwent monocular (single letter scored) visual acuity measurements using ETDRS charts 1 and 2, and charts of the same layout but constructed using VO letters (VO1 and VO2). All tests were performed in a random sequence. The methods of Bland and Altman were employed with test-retest variability (TRV) expressed as 95% confidence intervals for agreement.

Results: Visual acuity measurements with the VO chart were, on average, approximately 3 logMAR lines ‘worse’ than those with conventional letter design in subjects with AMD compared to a difference of only 1.5 logMAR lines in normal subjects. This difference between the two groups was statistically significant (p<0.05, unpaired t-test). Similar TRV’s of approximately +/- 0.10 logMAR were found for both the ETDRS and VO charts in both groups.

Conclusions: AMD patients display a measurably larger visual acuity deficit using VO letter charts compared to conventional ETDRS charts, with no significant difference in test-retest variability.

Keywords: 754 visual acuity • 412 age-related macular degeneration  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×